MedPath

AL MAARIF UNIVERSITY COLLEGE

🇮🇶Iraq
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:2

Trial Phases

0 Phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Estimation of (suPAR) in Chronic Periodontitis With Post-radiotherapy on HNCs Patients

Completed
Conditions
Head and Neck Cancer
Chronic Periodontitis
Radiotherapy Side Effect
First Posted Date
2024-07-31
Last Posted Date
2024-07-31
Lead Sponsor
Al-Maarif University College
Target Recruit Count
150
Registration Number
NCT06529588
Locations
🇮🇶

Ahmed A. Al-Kubaisi, Ramadi, Anbar, Iraq

suPAR is a Potential Biomarker of in Chronic Periodontitis Through the Impact of Post-radiotherapy on HNCs Patients

Completed
Conditions
Radiotherapy; Complications
Chronic Periodontitis
Head and Neck Cancer
First Posted Date
2024-07-01
Last Posted Date
2024-07-01
Lead Sponsor
Al-Maarif University College
Target Recruit Count
150
Registration Number
NCT06481059
Locations
🇮🇶

Ahmed A. Al-Kubaisi, Ramadi, Anbar, Iraq

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.